Clinical Trial Update: Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

View source ↗

Summary

A completed clinical trial evaluating drug concentrations, immunogenicity, and efficacy in rheumatoid arthritis patients already treated with TNF inhibitors (et…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Etanercept (etanercept)
• Infliximab (infliximab)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-01-12